Rajiv Khanna BSc, MSc, PhD

Prof. Rajiv Khanna obtained his doctorate degree from India and undertook his post-doctoral training at the Queensland Institute of Medical Research (QIMR), Brisbane Australia. He is the Coordinator of QIMR Berghofer Centre for Immunotherapy and Vaccine Development. He holds Senior Principal Research Fellowship from the National Health and Medical Research Council of Australia and is also appointed as Honorary Professor at the University of Queensland and Griffith University, Brisbane, Australia. Prof. Khanna is a Fellow of Australian Academy of Health and Medical Sciences.

He has extensive expertise in immunotherapy clinical trials, cancer immunology and vaccine development. Prof. Khanna has been appointed as a consultant to Atara Biotherapeutics (US), CSL Ltd, Cellestis Ltd and Oxford Immunotech (UK) for the development of novel immunotherapeutics, diagnostic technologies, and vaccines. He is also appointed on Scientific Advisory Board of Atara Biotherapeutics. Khanna has been invited by International Transplant Society to participate in the development of guidelines for the clinical management of cytomegalovirus infection in solid organ transplant patients.